Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1

被引:162
|
作者
Otero, M
Lago, R
Lago, F
Reino, JJG
Gualillo, O [1 ]
机构
[1] Santiago Univ Clin Hosp, NEIRID Lab, Res Lab 4, Santiago De Compostela, Spain
[2] Santiago Univ Clin Hosp, Lab Mol & Cellular Cardiol, Res Lab 1, Santiago De Compostela, Spain
[3] Santiago Univ Clin Hosp, Div Rheumatol, Santiago De Compostela, Spain
[4] Univ Santiago de Compostela, Sch Med, Dept Med, Santiago De Compostela, Spain
关键词
D O I
10.1186/ar1708
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the present study was to investigate the effect of leptin, alone or in combination with IL-1, on nitric oxide synthase ( NOS) type II activity in vitro in human primary chondrocytes, in the mouse chondrogenic ATDC5 cell line, and in mature and hypertrophic ATDC5 differentiated chondrocytes. For completeness, we also investigated the signalling pathway of the putative synergism between leptin and IL-1. For this purpose, nitric oxide production was evaluated using the Griess colorimetric reaction in culture medium of cells stimulated over 48 hours with leptin (800 nmol/l) and IL-1 (0.025 ng/ml), alone or combined. Specific pharmacological inhibitors of NOS type II (aminoguanidine [1 mmol/l]), janus kinase (JAK) 2 (tyrphostin AG490 and Tkip), phosphatidylinositol 3-kinase (PI3K; wortmannin [1, 2.5, 5 and 10 mu mol/l] and LY294002 [1, 2.5, 5 and 10 mu mol/l]), mitogen-activated protein kinase kinase (MEK) 1 (PD098059 [1, 5, 10, 20 and 30 mu mol/l]) and p38 kinase (SB203580 [1, 5, 10, 20 and 30 mu mol/l]) were added 1 hour before stimulation. Nitric oxide synthase type II mRNA expression in ATDC5 chondrocytes was investigated by real-time PCR and NOS II protein expression was analyzed by western blot. Our results indicate that stimulation of chondrocytes with IL-1 results in dose-dependent nitric oxide production. In contrast, leptin alone was unable to induce nitric oxide production or expression of NOS type II mRNA or its protein. However, co-stimulation with leptin and IL-1 resulted in a net increase in nitric oxide concentration over IL-1 challenge that was eliminated by pretreatment with the NOS II specific inhibitor aminoguanidine. Pretreatment with tyrphostin AG490 and Tkip (a SOCS-1 mimetic peptide that inhibits JAK2) blocked nitric oxide production induced by leptin/IL-1. Finally, wortmannin, LY294002, PD098059 and SB203580 significantly decreased nitric oxide production. These findings were confirmed in mature and hypertrophic ATDC5 chondrocytes, and in human primary chondrocytes. This study indicates that leptin plays a proinflammatory role, in synergy with IL-1, by inducing NOS type II through a signalling pathway that involves JAK2, PI3K, MEK-1 and p38 kinase.
引用
收藏
页码:R581 / R591
页数:11
相关论文
共 50 条
  • [31] Multiple signalling pathways account for the synergistic induction of MMP-1 by interleukin-1 in combination with oncostatin M in chondrocytes.
    Rowan, AD
    Catterall, JB
    Carrere, S
    Koshy, PJT
    Shingleton, WD
    Degnan, BA
    Rutter, J
    Brinckerhoff, CE
    Cawston, TE
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S85 - S85
  • [32] Induction of nitric oxide synthase and over-production of nitric oxide by interleukin-1β in cultured lacrimal gland acinar cells
    Beauregard, C
    Brandt, PC
    Chiou, GCY
    EXPERIMENTAL EYE RESEARCH, 2003, 77 (01) : 109 - 114
  • [33] INHIBITION OF NITRIC-OXIDE SYNTHASE POTENTIATES THE BEHAVIORAL-EFFECTS OF INTERLEUKIN-1 IN THE MOUSE
    BLUTHE, RM
    SPARBER, S
    KENT, S
    DANTZER, R
    JOURNAL OF PHYSIOLOGY-LONDON, 1992, 452 : P123 - P123
  • [34] Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints
    De Mello S.B.V.
    Novaes G.S.
    Laurindo I.M.M.
    Muscará M.N.
    De Barros Maciel F.M.
    Cossermelli W.
    Inflammation Research, 1997, 46 (2) : 72 - 77
  • [35] Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints
    deMello, SBV
    Novaes, GS
    Laurindo, IMM
    Muscara, MN
    Maciel, FMD
    Cossermelli, W
    INFLAMMATION RESEARCH, 1997, 46 (02) : 72 - 77
  • [36] Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1β in rats
    Presle, N
    Cipolletta, C
    Jouzeau, JY
    Abid, A
    Netter, P
    Terlain, B
    ARTHRITIS AND RHEUMATISM, 1999, 42 (10): : 2094 - 2102
  • [37] Tumour necrosis factor and interleukin-1 are mediators of the induction of nitric oxide synthase by endotoxin in vivo
    Szabo, C
    Thiemermann, C
    Wu, CC
    Vane, JR
    IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL I: MOF, MODS AND SIRS - BASIC MECHANISMS IN INFLAMMATION AND TISSUE INJURY, 1996, : 758 - 763
  • [38] Interleukin-1β and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation
    Montolio, Marta
    Biarnes, Montse
    Tellez, Noelia
    Escoriza, Jessica
    Soler, Joan
    Montanya, Eduard
    JOURNAL OF ENDOCRINOLOGY, 2007, 192 (01) : 169 - 177
  • [39] Role of the nitric oxide/cyclic GMP/Ca2+ signaling pathway in the pyrogenic effect of interleukin-1β
    Palmi, M
    Meini, A
    MOLECULAR NEUROBIOLOGY, 2002, 25 (02) : 133 - 147
  • [40] Role of the nitric oxide/cyclic GMP/Ca2+ signaling pathway in the pyrogenic effect of interleukin-1β
    Mitri Palmi
    Antonella Meini
    Molecular Neurobiology, 2002, 25 : 133 - 147